Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
**CarvaNum** is a proprietary topical muscle-recovery product originated by Innovus Pharmaceuticals. Innovus described the legacy European formulation as a cream containing carvacrol, l-arginine, l-citrulline, and magnesium sulfate, intended to support muscle strength, blood flow, and prevention of muscle cramps; the company received European Union cosmetic-product notification for muscle recovery and stated that it was pursuing a homeopathic-drug filing for muscle cramps in the United States and Canada. ([businesswire.com](https://www.businesswire.com/news/home/20190606005218/en/Innovus-Pharmaceuticals-Receives-Notification-to-Market-and-Sell-CarvaNum%C2%AE-for-Muscle-Recovery-in-the-European-Union)) A separately documented U.S. OTC NDC listing under the same brand identifies CarvaNum as a menthol 0.5% topical lotion for temporary relief of minor muscle and joint aches and pains, indicating that the brand name has been associated with formulation-specific products. ([fda.report](https://fda.report/NDC/57483-301))
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on CarvaNum.